جست‌وجوی استاد و پژوهشگر

Nazir Barekziمشاهده پروفایل

دانشیار

• Bacteriophage Research
• Microbiology
• Cancer Biology
• +۳ مورد دیگر

Dr. Nazir Barekzi is an Associate Professor of Biology at the Department of Biology, College of Science, Engineering and Technology, Norfolk State University. His research focuses on bacteriophage discovery, genomics, microbiology, and innovative teaching methods in undergraduate education. He is actively involved in course-based undergraduate research experiences (CUREs) and inclusive pedagogy to enhance student outcomes in STEM fields. His research spans bacteriophage genomics, cancer cell biology, and plasma-based therapeutic applications. Notable contributions include studies on phage therapy for bacterial pathogens and the anti-tumor effects of plasma-activated media. He has also explored the efficacy of low-temperature plasma devices like the plasma pencil in cancer treatment. Barekzi’s publications reflect interdisciplinary work across microbiology, oncology, and biotechnology. His recent studies emphasize the impact of community-focused CUREs on student identity and career trajectories at Historically Black Colleges and Universities (HBCUs). He advises multiple graduate and undergraduate students, including Malikah Abdullah, Ashley Haines, and others. His work bridges basic science research with practical educational innovations, contributing to both academic and clinical advancements.

Carol A. Eisenbergمشاهده پروفایل

دانشیار

• Stem Cell Biology
• Cardiovascular Research
• Cell Signaling
• +۳ مورد دیگر

Carol A. Eisenberg, Ph.D., is an Associate Professor in the Department of Physiology at New York Medical College, holding dual appointments in the School of Medicine. She is also Co-Director of the Stem Cell Laboratory. Her career integrates research, education, and administrative leadership. She joined NYMC in 2008 after 13 years at the Medical University of South Carolina. Education : B.S./B.A. in Biology and French, Cabrini College M.S. in Cell Biology, Villanova University Ph.D. in Cell Biology, Cornell University Medical College Postdoctoral Training in Cell Biology & Anatomy, Medical University of South Carolina Research Interests : Dr. Eisenberg’s lab focuses on three interconnected areas: 1. Signaling pathways activated in diseased hearts via the GATA6 gene enhancer. 2. Long-term maintenance of differentiated myocardial tissue in culture. 3. Stem cell differentiation for cardiomyocyte replacement. These projects aim to preserve adult heart function across lifespan. Professional Service : Chair, GSBMS Course Evaluation Committee (2014–present) Member, GSBMS Ph.D. Admissions Committee (2009–2021) Member, NYMC Diversity & Inclusion Committees (2014–present) Lab & Mentorship : As a mentor, she has guided four postdoctoral fellows, two Ph.D., and three M.S. students. She oversees lab activities for medical, undergraduate, and secondary school students. Her Stem Cell Laboratory collaborates across disciplines to advance cardiac regeneration therapies.

Laia Bosch Preseguéمشاهده پروفایل

استاد پژوهشی

• Biomedicine
• Epigenetics
• Molecular Biology
• +۳ مورد دیگر

Laia Bosch Presegué is a Research Professor affiliated with the Universitat de Vic – Universitat Central de Catalunya (UVic-UCC) and the Institute for Research and Innovation in Health Sciences of Central Catalonia (IRIS-CC). Her primary role includes leading the Biomedicine Workshops program, which bridges secondary education and university research in biomedical sciences. She also serves as Principal Investigator at the Josep Carreras Leukemia Research Institute in Barcelona, focusing on epigenetic mechanisms and cancer biology. Her research interests span epigenetics, molecular biology, and biomedical applications, with a focus on heterochromatin regulation, sirtuin enzymes, and the interplay between histone variants and chromatin structure. Collaborations include projects on DCIS lesion progression and sexual health impacts, as well as studies on rhodopsin mutations linked to retinitis pigmentosa. Recent work highlights the functional interplay between HP1 isoforms and H2A.Z in heterochromatin regulation, SIRT1's role in DNA damage signaling, and SIRT6-dependent modifications in tumor suppression. Bosch Presegué's initiatives have engaged over 1,000 high school students in hands-on biosciences labs, fostering early STEM interest. Her contributions span academic research, clinical applications, and science education, emphasizing translational medicine and epigenetic therapeutics.

Gabriella D'Oraziمشاهده پروفایل

دانشیار

• Molecular Oncology
• Tumor Suppressor p53
• HIPK2 Regulation
• +۳ مورد دیگر

Gabriella D'Orazi is an Associate Professor at UniCamillus University of Rome, specializing in General Pathology. She holds a PhD in Experimental Medicine (1992) from the University of Rome La Sapienza and a Master's in Dietetics and Human Nutrition (2003). Her career includes roles as a University Researcher (1992–2017) and Associate Professor (2017–2024) at the University ‘G. D’Annunzio’ of Chieti, alongside visiting appointments at the National Cancer Institute (NCI, NIH, Bethesda) and the National Cancer Institute ‘Regina Elena’ in Rome. Her research focuses on Molecular Oncology, particularly the regulatory mechanisms of tumor suppressor p53 and HIPK2 in cancer progression and therapy response. She has authored over 137 peer-reviewed publications (H-index: 47), is a member of editorial boards for international journals, and is recognized as a Top Italian Scientist in Biomedical Sciences (2024). Teaching responsibilities include Pathology and Pathophysiology across multiple degree programs at UniCamillus, as well as roles in academic governance, such as coordinating courses and serving on commissions. Her work integrates translational research, drug development, and interdisciplinary approaches to cancer biology.

• Cancer Biology
• Prostate Cancer Research
• Molecular Oncology
• +۳ مورد دیگر

Dr. Praveen Kumar Jaiswal is an Assistant Instructor in the Department of Internal Medicine at UT Southwestern Medical Center, specializing in the Division of Hematology and Oncology. He joined the faculty in 2024 after completing postdoctoral training in urology and cancer research. His academic journey includes a PhD from King George's Medical University and postdoctoral fellowships at Sanjay Gandhi Post Graduate Institute of Medical Sciences and LSU Health Sciences Center. Dr. Jaiswal's research focuses on prostate cancer mechanisms, treatment resistance, and targeted therapies. His work explores signaling pathways such as the Hippo pathway, cAMP/PKA signaling, and translational control via EIF4G1. He has published extensively in peer-reviewed journals and serves on editorial boards, including Journal of Histotechnology and BMC Cancer . In 2019, he received the American Urological Association's Research Scholar Award. Professional Societies: American Society for Biochemistry and Molecular Biology, American Association for Cancer Research, European Association for Cancer Research Research Interests: Molecular oncology, cancer therapeutics, signal transduction His articles highlight therapeutic targeting of proteins like TLK1/NEK1 and PDEF, while his recent work addresses castration-resistant prostate cancer and miRNA variants in renal cell carcinoma. Dr. Jaiswal actively presents at global conferences and contributes to book chapters, emphasizing translational research in oncology.

• Molecular Biology
• Cellular Biology
• Nutrition Science
• +۴ مورد دیگر

Nicolas BARBEZIER is an Associate Professor in Molecular and Cellular Biology affiliated with the EGEAL research unit. His work focuses on understanding the impacts of dietary components and environmental contaminants on intestinal health, microbiota dynamics, and chronic disease mechanisms. He holds a PhD from the University of Perpignan Via Domitia and specializes in translational research bridging basic biology, nutrition science, and veterinary medicine. Research interests include the effects of advanced glycation end-products (AGEs), plant-derived tannins, and nutritional interventions on gut integrity, immune responses, and microbiome composition. His studies often utilize in vitro models of intestinal barriers and animal husbandry systems to evaluate novel nutritional solutions for improving health outcomes in both humans and livestock. Key contributions span over 20 peer-reviewed articles since 2006, with recent work emphasizing early-life exposure to contaminants, microbiota modulation in weaned piglets, and the mechanistic basis of muscular dystrophies linked to proteostasis defects. His interdisciplinary approach integrates molecular biology techniques, advanced analytical chemistry, and systems biology to address multifaceted health challenges. Current affiliations include collaborative research within the EGEAL unit, focusing on developing biomimetic in vitro systems and exploring natural compounds for biomedical and agricultural applications.

• Environmental Toxicology
• Neurotoxicology
• Epigenetics
• +۳ مورد دیگر

Henri Schroeder is a Professor specializing in environmental and neurotoxicology, focusing on the effects of chemical pollutants on human and animal health. His research emphasizes understanding the toxicity of persistent organic pollutants (POPs), endocrine disruptors, and their impacts on neurodevelopment, epigenetic modifications, and metabolic disorders. He has contributed significantly to regulatory risk assessments for substances like PBDEs, BPA, and polycyclic aromatic hydrocarbons (PAHs), collaborating with agencies like EFSA and ANSES. His work bridges laboratory-based studies with real-world exposure scenarios, particularly examining gestational and early-life exposures to pollutants. Key areas of expertise include: - Neurodevelopmental toxicity of environmental contaminants - Epigenetic mechanisms in pollutant-induced disorders - Pharmacokinetic modeling of toxicants - Regulatory risk assessment methodologies - Animal model validation for neurotoxicity studies His research employs advanced techniques such as metabolomics, bioinformatics, and histopathological analyses, supported by institutional platforms like the Functional Genomics Platform and Molecular Biology facilities. Recent studies highlight the interplay between circadian rhythm disruption, neuroinflammation, and hepatic steatosis in pollutant-exposed organisms.

Xiao-Feng Yangمشاهده پروفایل

استاد

• Cardiovascular Sciences
• Epigenetic Pathology
• Vascular Inflammation
• +۴ مورد دیگر

Xiao-Feng Yang, MD, PhD, FAHA is a Professor and Associate Director at the Lemole Center for Integrated Lymphatics and Vascular Research at Temple University's Lewis Katz School of Medicine. He holds multiple professorial appointments across departments including Cardiovascular Sciences, Microbiology, Immunology and Inflammation, and Biomedical Education and Data Science. His research focuses on epigenetic mechanisms in cardiovascular diseases (CVD), particularly how CVD risk factors influence histone modification and gene expression in vascular inflammation and atherosclerosis. Education: MD from JiangXi Medical University (1979), MS in Immunology from Chinese National Academy of Medical Sciences (1982), PhD in Biochemistry from University of Montreal (1994), and fellowship training in Immunology at Harvard Medical School (1999). Research interests span epigenetic pathology, metabolic disease pathways, thrombosis, and vascular immunology. Notable contributions include studies on metabolic crosstalk in metabolic syndrome, lysophospholipid signaling in atherosclerosis, and regulatory T cell epigenetics. His work integrates basic science with translational medicine, addressing mechanisms of vascular inflammation and therapeutic targets. Awards include Fellow of the American Heart Association (FAHA). Active in multiple research centers including the Sol Sherry Thrombosis Research Center and Center for Metabolic Disease Research. His publications (over 100) emphasize interdisciplinary approaches to cardiovascular and metabolic disorders.

• Biostatistics
• Statistical Genetics
• Genetic Epidemiology
• +۳ مورد دیگر

Hemant Tiwari is a full-time Professor of Biostatistics at the University of Alabama at Birmingham (UAB) School of Public Health , with simultaneous senior scientist appointments at multiple UAB research centers including the Nephrology Research & Training Center and Center for Clinical and Translational Science (CCTS) . Holding a PhD in Mathematics from the University of Notre Dame, he transitioned to statistical genetics through postdoctoral work at LSU Medical Center and Case Western Reserve University, joining UAB in 2002. Doctor of Philosophy, Mathematics - University of Notre Dame (1986) His research focuses on genetic epidemiology , epigenetics , and multi-omics analysis of complex diseases like stroke, obesity, and autoimmune disorders. He has pioneered methods for polygenic risk score calibration and ancestry-specific genomic studies , particularly in African American populations. Recent work highlights include machine learning stroke prediction models for Sub-Saharan Africa and African ancestry-specific BMI risk alleles . Grants from the National Heart, Lung, and Blood Institute and American Heart Association support his research on cardiorenal genomics and stress-induced epigenetic modifications. As Vice Chair for Research and Faculty Development , he oversees academic initiatives while maintaining active collaborations across UAB's Comprehensive Diabetes Center , Cancer Center , and other multidisciplinary hubs.

• Synthesis of organic small molecules
• Flow chemistry
• Molecular bio-conjugation
• +۵ مورد دیگر

Floris Rutjes is a Full Professor and Chair of Synthetic Organic Chemistry at Radboud University's Faculty of Science in Nijmegen, The Netherlands. He has held this position since 1999 and previously served as Assistant Professor at the University of Amsterdam (1995-1999). Currently, he also serves as President of the European Chemical Society (EuChemS) since 2021 and directs the Institute for Molecules and Materials (IMM) at Radboud University. Professor Rutjes specializes in the synthesis of organic small molecules with research spanning four major areas: (i) New Synthetic Methods involving chemo-enzymatic and transition metal-catalyzed reactions to produce enantiopure heterocyclic building blocks; (ii) Medicinal Chemistry focusing on biologically active small molecules; (iii) Molecular Bioconjugation developing 'click' probes like BCN and DIBAC/DBCO that are now used in clinical trials for antibody-drug conjugates; and (iv) Flow Chemistry where he pioneered the use of continuous flow microreactors in organic synthesis. His work uniquely bridges fundamental academic research with industrial applications. His publication record shows consistent contributions to organic chemistry, with recent work (2021-2017) emphasizing advanced spectroscopic techniques, hyperpolarization methods for NMR detection, novel catalytic systems, and applications in medicinal chemistry. The research demonstrates a strong trajectory from fundamental chemical methodologies toward biomedical applications, particularly in drug development and diagnostic techniques. Among his notable honors: Chemistry Europe Fellow (2022) Knight in the Order of the Netherlands Lion (2020) Most Entrepreneurial Scientist of the Netherlands Award (2008) International AstraZeneca Award for Research in Organic Chemistry (2003) Gold Medal of the Royal Netherlands Chemical Society (2002) Professor Rutjes has successfully secured significant research funding, including a €1.5M grant from the Top-sector Health-Holland program to develop antiviral compounds against COVID-19, and leads multiple international consortia including an EU-Eurostar project for PTSD treatments and the COILED project for immunity research. His entrepreneurial spirit is evident through spin-off companies like Chiralix (2002) and FutureChemistry (2008), with several other companies including Synaffix and COILED Therapeutics founded based on research conducted under his guidance. As Director of the Institute for Molecules and Materials, he oversees a multidisciplinary research environment spanning organic chemistry, solid-state NMR, microfluidics, and MRI imaging. His collaborations extend to the Fraunhofer Institute in Germany, Eindhoven University of Technology, and multiple pharmaceutical companies, creating a robust ecosystem for translating chemical innovations into practical applications.

Michael Sacherمشاهده پروفایل

استاد

• Membrane Traffic
• Vesicle Recognition
• TRAPP-opathies
• +۵ مورد دیگر

Michael Sacher is a Professor in the Department of Biology at Concordia University. His research focuses on membrane traffic, vesicle recognition, and TRAPP complex-related disorders, particularly TRAPP-opathies and TANGO2 deficiency diseases. He holds a PhD from McGill University and has been awarded grants from CIHR, NSERC, and the TANGO2 Research Foundation. His work combines cell biology, genetics, and clinical research to understand disease mechanisms and develop therapeutic strategies. Key contributions include studies on autophagy regulation, protein glycosylation defects, and the molecular basis of muscular dystrophies. Teaching activities include Cell Biology (Biol 266) and Advanced Laboratory in Molecular Biology (Biol 466/689). His lab investigates the TRAPP complex’s role in organelle communication, with recent studies highlighting lipid imbalances in TANGO2 deficiency and vitamin B5’s therapeutic potential. Awards include the CIHR New Investigator Award (2007-2012) and the Maud Menten Prize (2007). His research bridges basic science and clinical applications, with ongoing work on patient-derived cell models and zebrafish/humanized yeast systems. Lab Website: Visit our lab pages Grants: CIHR, NSERC, Concordia University, TANGO2 Foundation Recent Focus: TRAPP mutations in neurodevelopmental disorders, autophagy regulation, and ER-Golgi trafficking defects

Axel Behrensمشاهده پروفایل

استاد

• Stem Cell Biology
• Ubiquitylation
• Transcription
• +۵ مورد دیگر

Axel Behrens is a prominent academic and researcher in the field of Biochemistry & Molecular Biology, currently holding the position of Senior Group Leader at The Francis Crick Institute in London, UK. He is also a Principal Fellow at King's College London and an Honorary Full Professor at University College London. Behrens is an EMBO member and has received an ERC Grant for his work. Education: Biological Sciences at Universities of Innsbruck and Vienna, Diploma and PhD from University of Vienna Academic: Honorary Full Professor at University College London, Senior Group Leader at The Francis Crick Institute Professional: Senior Scientist at Cancer Research UK, Principal Fellow at King's College London Behrens' research focuses on multiple areas including stem cells, ubiquitylation, transcription, DNA damage, and cancer biology. His work has particularly explored the role of the c-Jun protein in cellular processes, the function of Fbw7 in intestinal homeostasis and cancer, and the role of ATM signaling pathways in genomic stability. His recent publications (2011-2015) demonstrate a strong focus on molecular mechanisms in cancer development, particularly in intestinal and lung cancers, as well as the role of ubiquitin ligases and proteases in cell biology. These works explore areas such as: c-Jun phosphorylation and activation Ubiquitin-mediated protein degradation ATM signaling pathways Intestinal homeostasis and tumorigenesis Neuronal regeneration Pancreatic cell differentiation Axel Behrens has received several notable scientific awards including: EMBO Young Investigator Programme (2004) ERC Grant (2011) EMBO Membership (2012)

Alexey Bogdanovمشاهده پروفایل

استاد

• Biochemistry of nucleic acid-protein complexes
• Nucleic acid-protein interactions
• Ribosome structure and mechanism of translation
• +۳ مورد دیگر

Alexey Bogdanov is a Professor at the Chemistry Faculty of Lomonosov Moscow State University, affiliated with the A.N. Belozersky Institute of Physico-Chemical Biology. His research focuses on ribosome structure and translation mechanisms, particularly nucleic acid-protein interactions and rRNA modifications. Member of Academia Europaea Foreign Member of Lithuanian Academy of Sciences Recipient of M.M. Shemyakin Prize, Fullbright Prize, and Alexander von Humboldt Prize His recent publications investigate rRNA methylation, ribosome subunit association, and translation termination mechanisms, with applications in understanding antibiotic interactions and RNA modifications. His work spans biochemistry, molecular biology, and structural biology, contributing to foundational knowledge in ribosomal function and translation regulation.

Kyle Biggarمشاهده پروفایل

دانشیار

• Functional Proteomics
• Protein Post-Translational Modifications
• Lysine Methylation
• +۶ مورد دیگر

Kyle Biggar is an Associate Professor at the Department of Biology, Faculty of Science, Carleton University. His research bridges functional proteomics, post-translational modifications (particularly lysine methylation), and their roles in cancer and hypoxia. He leads a multidisciplinary lab with expertise in biochemical techniques, peptide array synthesis, and computational modeling of enzyme-substrate interactions. Education: B.Sc. (St. Francis Xavier), Ph.D. (Carleton) Research Themes: Regulation of protein interaction networks by lysine methylation, hypoxia signaling, therapeutic peptide design, and environmental stress adaptation Collaborations: Co-supervises students with Dr. James Green, partners with NuvoBio for cancer therapeutics His publications focus on enzyme specificity, methyllysine proteomics, and stress-responsive microRNA mechanisms. The lab trains students in advanced cellular and biochemical methods, with alumni contributing to fields like neurodegenerative disease and DNA repair. Recent work includes AI-driven protein interaction prediction, exploring lysine PTM competition in cancer, and developing KDM5C/SETD6 inhibitors. The lab also investigates mTOR-IGFBP-1 signaling in intrauterine growth restriction and employs peptide arrays for drug discovery. Lab Members & Students: Current: Francois Charih (NSERC PGS-D), Ruofan Wang, Mullen Boutler, Mitch Allen, Ella De Nicola, Johanna Enright Alumni: Dr. Hemanta Adhikary (KMT/KDM inhibitors), Viktoria Xing (methyl-binding domains), Ryan Collins (MLL4 substrates)

Neil Wardمشاهده پروفایل

استاد

• Net Zero
• Food and Farming
• Rural Economy
• +۷ مورد دیگر

Neil Ward is a Professor of Rural and Regional Development at the University of East Anglia (UEA), where he also served as Deputy Vice Chancellor and PVC-Academic from 2013 to 2021. He holds a background in geography, having begun his academic career at University College London and held chairs at the University of Leeds and Newcastle University, where he directed the Centre for Rural Economy (2004–2008). His research focuses on rural economic and social change, agricultural policy, environmental controversies, and regional development. He is a co-convenor of UKRI’s AgriFood4NetZero Network+ (2022–2025) and authored Net Zero, Food and Farming: Climate Change and the UK Agri-Food System (Routledge, 2022). Education: Geographer by training, with academic roles at UCL, Leeds, and Newcastle. Affiliations: School of Environmental Sciences, UEA; Tyndall Centre for Climate Change Research. Roles: Former Deputy Vice Chancellor, UEA; advisor to the Economic and Social Research Council. His work aligns with UN Sustainable Development Goals, particularly those addressing poverty reduction, climate action, and sustainable agriculture. He has extensive collaboration networks in environmental policy, rural development, and food systems. Research Highlights: Recent projects include AgriFood4NetZero, exploring pathways to net-zero agrifood systems, and studies on methane emissions from manure, UK food system resilience, and rural policy. His publications span agricultural economics, climate policy, and interdisciplinary methodologies. Awards: Fellow of the Academy of Social Sciences (2008), Principal Fellow of the Higher Education Academy. Grants: Led projects funded by UK Research Councils, including AgriFood4NetZero (EPSRC) and EVOLVE initiatives. Labs/Teams: Collaborates with the Tyndall Centre and contributes to multidisciplinary networks in climate change and food systems.